Home Home Home Inbox Home Search

Event

Pharmacodynamic and Clinical Efficacy Data from Patient Sputum Subgroups in DREAM Treated with Mepolizumab Across a 10-Fold Dose Range [Board No. P919]

Location: Board no. P919
Session Type: Thematic Poster Session
Sunday
May
20
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Rohit Katial

MD
GlaxoSmithKline

Peter H. Howarth

DrMed, MBBS, MD, DMD, DMD
GSK

Hector Ortega

MD, ScD
GlaxoSmithKline;GSK

Steven W. Yancey

MBA, MS
GlaxoSmithKline;GSK

Eric Speir. Bradford

MD
GlaxoSmithKline;GSK

Charlene Prazma

PhD
GlaxoSmithKline

View Abstract

Pharmacodynamic and Clinical Efficacy Data from Patient Sputum Subgroups in DREAM Treated with Mepolizumab Across a 10-Fold Dose Range

Parent Sessions

  • A34 - ASTHMA CLINICAL STUDIES I
    05-20-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search